Company
Why Investors Should Stick to Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) Stock in 2025
In the last trading session, 3.96 million Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) shares changed hands as the company’s beta touched 0.26. With the company’s per share